Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Melissa Jameson"'
Autor:
Wendy J Haydon, Kathryn Eagye, Jad Hayes, Marcus A. Neubauer, Mitra Abdullahpour, Maria Sipala, J. Russell Hoverman, Michael A. Kolodziej, Diana K. Verrilli, Amy Supraner, Melissa Jameson
Publikováno v:
Journal of oncology practice. 14(4)
Purpose: Reform of cancer care delivery seeks to control costs while improving quality. Texas Oncology collaborated with Aetna to conduct a payer-sponsored program that used evidence-based treatment pathways, a disease management call center, and an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8abb519593131b56965aac1ae8efa6d
https://pubmed.ncbi.nlm.nih.gov/29547343
https://pubmed.ncbi.nlm.nih.gov/29547343
Autor:
Jessica McQueen, Scott Houldin, Maria Sipala, Mitra Abdullahpour, Greg C. Nelson, Ira Klein, Debra W. Harrison, Melissa Jameson, J. Russell Hoverman, Robyn K. Harrell, Marcus A. Neubauer, Jad Hayes, Jody S. Garey, Diana K. Verrilli
Publikováno v:
Journal of oncology practice. 10(1)
The Innovent Oncology Program aims to improve the value of cancer care delivered to patients. McKesson Specialty Health and Texas Oncology (TXO) collaborated with Aetna to launch a pilot program. The study objectives were to evaluate the impact of In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd295c389734c98d3e9b7441a19cf7d
https://pubmed.ncbi.nlm.nih.gov/24443735
https://pubmed.ncbi.nlm.nih.gov/24443735
Autor:
Marcus A. Neubauer, Diana K. Verrilli, Maria Sipala, Wendy J Haydon, J. Russell Hoverman, Amy Supraner, Melissa Jameson, Jad Hayes, Michael Kolodziej, Mitra Abdullahpour
Publikováno v:
Journal of Clinical Oncology. 34:6505-6505
6505Background: Cancer care delivery and reimbursement reform are focused on controlling costs and improving quality, thereby increasing value. Medicare-age patients have more cancer and more co-mo...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c7da55f7195652fec264c7b9ae24d76
https://doi.org/10.1200/jco.2016.34.15_suppl.6505
https://doi.org/10.1200/jco.2016.34.15_suppl.6505
Autor:
Mitra Abdullahpour, Marcus A. Neubauer, Michael Kolodziej, Kathryn Eagye, Amy Supraner, Melissa Jameson, Maria Sipala, J. Russell Hoverman
Publikováno v:
Journal of Clinical Oncology. 34:84-84
84 Background: Cancer patients receiving chemotherapy can become ill, often leading to hospitalization, adding huge costs to care. This is especially true with older cancer patients. Innovent Oncology (IO), an oncology disease management program, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::047181e48ae2da4f4ccf8ab6ffe59dbc
https://doi.org/10.1200/jco.2016.34.7_suppl.84
https://doi.org/10.1200/jco.2016.34.7_suppl.84
Autor:
Mitra Abdullahpour, Jad Hayes, Maria Sipala, Cynthia Taniguchi, Kathryn Eagye, J. Russell Hoverman, Amy Supraner, Michael Kolodziej, Marcus A. Neubauer, Melissa Jameson
Publikováno v:
Journal of Clinical Oncology. 33:e17712-e17712
e17712 Background: Patient-provider discussion of future healthcare decisions in accordance with patient values—ACP—is especially relevant for metastatic cancer patients. Extending survival is the ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ca1278e8e146dfca07d308ebe32599a
https://doi.org/10.1200/jco.2015.33.15_suppl.e17712
https://doi.org/10.1200/jco.2015.33.15_suppl.e17712
Autor:
Kathryn Eagye, Melissa Jameson, Michael Kolodziej, Amy Supraner, Jad Hayes, Vanessa Torres, Maria Sipala, Marcus A. Neubauer, J. Russell Hoverman
Publikováno v:
Journal of Clinical Oncology. 33:e19117-e19117
e19117 Background: A recent report identifies hospitalization as the principal driver of both cost and regional variation in advanced cancer. Understanding risks for inpatient admission (IPA) would...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6326b4465375a7ca214a08cdf750ce0
https://doi.org/10.1200/jco.2015.33.15_suppl.e19117
https://doi.org/10.1200/jco.2015.33.15_suppl.e19117
Autor:
Kathryn Eagye, Cynthia Taniguchi, Jad Hayes, Mitra Abdullahpour, Melissa Jameson, J. Russell Hoverman, Marcus A. Neubauer
Publikováno v:
Journal of Clinical Oncology. 32:73-73
73 Background: Utilizing a telephonic disease management (DM) model for educating and assisting patients to self-manage treatment side effects is a known element of practice quality. Yet, disease management models frequently neglect important aspects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86766d344ad058bf2ce80f0540469bef
https://doi.org/10.1200/jco.2014.32.30_suppl.73
https://doi.org/10.1200/jco.2014.32.30_suppl.73
Autor:
Janet L. Espirito, Deb Harrison, M. Clayton, Robyn K. Harrell, Jessica McQueen, Mitra Abdullahpour, J. Russell Hoverman, Melissa Jameson
Publikováno v:
Journal of Clinical Oncology. 31:147-147
147 Background: Telephonic nursing (RN) outreach was provided as part of an oncology disease management program to provide symptom (sx) management education, assess patient-reported sxs during treatment (tx), and reduce acute care utilization. The Ed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::390febf6af83fd276ad691f66f7f874c
https://doi.org/10.1200/jco.2013.31.31_suppl.147
https://doi.org/10.1200/jco.2013.31.31_suppl.147
Autor:
Cynthia Taniguchi, Jad Hayes, Diana K. Verrilli, Marcus A. Neubauer, Jody S. Garey, John Ciaglo, Jessica McQueen, Scott Houldin, Melissa Jameson, Deb Harrison, Greg C. Nelson, Ira Klein, Robyn K. Harrell, Mitra Abdullahpour, Maria Sipala, J. Russell Hoverman
Publikováno v:
Journal of Clinical Oncology. 31:119-119
119 Background: The Innovent Oncology Program (IOP) addresses rising costs of cancer treatment but maintains the use of evidence-based medicine. McKesson Specialty Health and Texas Oncology (TXO) collaborated with Aetna, Inc to launch a pilot program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ef4b14ea19712f64941d2cd03827a49
https://doi.org/10.1200/jco.2013.31.31_suppl.119
https://doi.org/10.1200/jco.2013.31.31_suppl.119
Autor:
Deb Harrison, Cynthia Taniguchi, Jessica McQueen, Mitra Abdullahpour, Greg C. Nelson, Ira Klein, Roy A. Beveridge, John Ciaglo, Jad Hayes, Diana K. Verrilli, Jody S. Garey, Scott Houldin, Melissa Jameson, Maria Sipala, J. Russell Hoverman
Publikováno v:
Journal of Clinical Oncology. 30:227-227
227 Background: US Oncology, Inc., Texas Oncology (TxO) and Aetna are engaged in a pilot program, Innovent Oncology (IOP) to evaluate clinical and financial impacts of Pathways (PW), a nursing call intervention for chemotherapy patients (pt support s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de4bac6fa6acbfe790eb45ef7688f3a4
https://doi.org/10.1200/jco.2012.30.34_suppl.227
https://doi.org/10.1200/jco.2012.30.34_suppl.227